Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Molecular Therapy - Nucleic Acids Année : 2019

Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine

Résumé

Nucleic acid vaccination relies on injecting DNA or RNA coding antigen(s) to induce a protective immune response. RNA vaccination is being increasingly used in preclinical and clinical studies. However, few delivery systems have been reported for in vivo delivery of RNA of different sizes. Using a tripartite formulation with RNA, cationic polymer, and anionic liposomes, we were able to encapsulate RNA into neutral lipopolyplexes (LPPs). LPPs were stable in vitro and successfully delivered conventional RNA and replicative RNA to dendritic cells in cellulo. Their injection led to reporter gene expression in mice. Finally, administration of LPP-Replicon RNA (RepRNA) led to an adaptive immune response against the antigen coded by the RepRNA. Accordingly, LPPs may represent a universal formulation for RNA delivery.

Domaines

Vaccinologie
Fichier principal
Vignette du fichier
FedericoPerche_2020_Neutral_lipopolyplexes_Molecular_Therapy_Nucleic_Acids.pdf (1.01 Mo) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-02321815 , version 1 (23-11-2020)

Identifiants

Citer

Federico Perche, Rudy Clemençon, Kai Schulze, Thomas Ebensen, Carlos Guzman, et al.. Neutral Lipopolyplexes for In Vivo Delivery of Conventional and Replicative RNA Vaccine. Molecular Therapy - Nucleic Acids, 2019, 17, pp.767-775. ⟨10.1016/j.omtn.2019.07.014⟩. ⟨hal-02321815⟩
97 Consultations
108 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More